Stock Events

Stock Events

Grace Therapeutics (GRCE) Q4 2024 Earnings

13NovConfirmed

Q3 2024

Q4 2024

-0.37

-0.33

-0.28

-0.24

Details

Expected EPS

-0.37

Actual EPS

-0.3

Surprise EPS

0.07

Surprise Percent

+18.92%

Description

Grace Therapeutics (GRCE) has reported earnings of -0.3 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.